House Panel Backs Cannabis Impairment Testing Standards in Transport Bill
Transportation committee advances legislation requiring federal study of marijuana DUI standards, addressing key regulatory gap hindering industry growth.
The House Transportation and Infrastructure Committee voted 61-2 to advance the Building Unrivaled Infrastructure and Long-term Development (BUILD) for America Act, which includes provisions mandating federal research into cannabis impairment standards for drivers. The legislation directs federal officials to study marijuana and other drug impairment while developing evidence-based testing protocols.
The overwhelming bipartisan support signals growing congressional recognition that existing DUI frameworks inadequately address cannabis use as legalization expands across states. Unlike alcohol, which has established blood alcohol content thresholds, law enforcement lacks standardized methods to determine marijuana impairment levels, creating legal uncertainties that complicate both criminal prosecutions and civil liability cases.
This regulatory gap has created headwinds for the cannabis industry's mainstream acceptance, particularly as employers, insurers, and transportation companies struggle with workplace safety protocols. The proposed federal standards could provide the regulatory clarity that institutional investors and large corporations require before fully engaging with cannabis markets, potentially unlocking significant capital flows.
The timing proves critical as more states implement adult-use programs while federal rescheduling discussions continue. Standardized impairment testing would address public safety concerns that often fuel opposition to legalization efforts, potentially smoothing the path for additional state-level reforms. The legislation also positions federal agencies to develop consistent protocols before broader federal cannabis policy changes occur.
While the bill must still pass the full House and Senate, the lopsided committee vote demonstrates rare bipartisan consensus on cannabis-related policy. The development of federal impairment standards represents essential infrastructure for a regulated cannabis market, addressing one of the most persistent challenges facing the industry's evolution from illicit to legitimate commerce.